Effects of chondroitin sulfate-C on bradykinin-induced proteoglycan depletion in rats

Citation
T. Omata et al., Effects of chondroitin sulfate-C on bradykinin-induced proteoglycan depletion in rats, ARZNEI-FOR, 49(7), 1999, pp. 577-581
Citations number
24
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
ISSN journal
00044172 → ACNP
Volume
49
Issue
7
Year of publication
1999
Pages
577 - 581
Database
ISI
SICI code
0004-4172(199907)49:7<577:EOCSOB>2.0.ZU;2-2
Abstract
Depletion of the proteoglycan content of articular cartilage was induced by injecting bradykinin (30-300 mu mol/l, 50 mu l/knee) into the left knee ar ticular cavities of rats 3 times a day for 2 days. The degree of the reduct ion in the intensity of histopathological safranin O staining was used as a n index of proteoglycan depletion. Bradykinin reduced the cartilage proteog lycan contents of the knee joints of non-injected limbs in a dose-dependent manner and at 300 mu mol/l markedly reduced these contents, but evoked no inflammatory changes. The extent of the reduction of the cartilage proteogl ycan contents induced by bradykinin injection depended on the dose and inje ction frequency. Chondroitin sulfate-C (CAS 25322-46-7, Chondroitin ZS Tab) (30-1,000 mg/kg/day) administered orally to rats for 14 days inhibited the bradykinin-induced proteoglycan depletion of the articular cartilage in a dose-dependent manner. These results suggest that a reduction of the proteglycan content of cartil age, like that associated with osteoarthritis, was induced by injecting bra dykinin into the knee articular cavities of rats and chondroitin sulfate-C protected against this effect.